Hidradenitis suppurativa GWAS in non-Hispanic white and non-Hispanic black ProCARE participants

Le résumé fourni par la source

Description: We performed population-stratified analyses including a total of 919 hidradenitis suppurativa (HS) cases and 4,628 controls. Participants and the overall analytic framework are described in Broadaway (2025), British Journal of Dermatology (PMID: 40650879). Briefly, HS ProCARE participants were evaluated and diagnosed at an outpatient dermatology clinic, and individuals from the Add Health cohort served as population-based controls without HS-specific screening. We excluded individuals with genotype missingness >5% or sex discordance and removed variants with missingness >5%. We imputed using the TOPMed Freeze 8 reference panel (hg38 build). We retained variants with imputation quality R² ≥ 0.8 within all four analysis groups (cases, controls, self-reported white, and self-reported black). We performed association testing using REGENIE v3.3 (--bt model). The analyses underlying these summary results differ from the published results in the following ways: - We restricted analyses to non-Hispanic White (NHW) and non-Hispanic Black (NHB) participants; other ancestry groups were excluded due to limited sample size. In the original analysis, participants were stratified as black and all other participants. - We confirmed the absence of clear ancestry outliers for these two groups using principal components analysis (PCA). - We performed population-stratified PCA analysis to include as covariates in the population-stratified (NHW and NHB) analyses. - We included the following covariates: sex, age, body mass index (BMI), and the first 4 ancestry-specific principal components. - Due to the additional screening, our sample sizes differ from the published sample sizes: NHW: 3976 total (415 cases, 3561 controls) NHB: 1564 total (497 cases, 1067 controls) Corresponding author: Christopher J Sayed (christopher_sayed@med.unc.edu)

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.